Calming the Storm

Addressing Life-Threatening Conditions Precipitated by the Cytokine Storm


A Strategy to Combat the #1 Cause of Hospital Deaths

Introducing Sigyn Therapy™, a multi-function blood purification technology designed to address both the cytokine storm* and the pathogen sources that fuel sepsis, the # 1 cause of hospital deaths.

*Cytokine Storm – a dysregulated immune response to infection that results in the excess production of inflammatory cytokines, which can cause tissue destruction, multiple organ failure and death.
Our Company
$20+ Billion

In the United States, the annual financial burden to treat sepsis alone is estimated to be $24 billion.*


*Global, regional and national sepsis incidence and mortality
The Journal Lancet, January 2020
Sigyn Therapy in Action
Sigyn Therapy in Action

Targeting Unmet Needs in Global Health

Beyond sepsis, Sigyn Therapy a candidate to address other unmet needs in global health.  These include, but are not limited to emerging pandemic threats, hepatic encephalopathy, bridge to liver transplant, and community-acquired pneumonia (CAP), which is a leading cause of death among infectious diseases.  CAP is also the leading cause of death in children under five years of age and the catalyst for approximately 50% of sepsis and septic shock cases. 

About Sigyn Therapy

Continuing Our Mission to Save Lives

Prior to establishing Sigyn Therapeutics, our co-founders played instrumental roles in the development of three different technologies that the United States Food and Drug Administration (FDA) has permitted for use to treat COVID-19 infected individuals.

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

Stock Information